artenimol has been researched along with dacarbazine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fang, SH; Huang, XJ; Li, CT; Lu, YB; Wei, EQ; Zhang, WP | 1 |
Blaes, J; Dong, Z; Green, E; Hertenstein, A; Jugold, M; Lemke, D; Löw, S; Ott, M; Platten, M; Pledl, HW; Sahm, F; Steffen, AC; Weiler, M; Wick, W; Winkler, F; Zorn, M | 1 |
2 other study(ies) available for artenimol and dacarbazine
Article | Year |
---|---|
Dihydroartemisinin potentiates the cytotoxic effect of temozolomide in rat C6 glioma cells.
Topics: Animals; Antineoplastic Agents; Antipyrine; Apoptosis; Artemisinins; Cell Survival; Cisplatin; Dacarbazine; Drug Synergism; Edaravone; Free Radical Scavengers; Glioma; Rats; Reactive Oxygen Species; Temozolomide; Tumor Cells, Cultured | 2008 |
Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapy.
Topics: Animals; Antimalarials; Artemisinins; Brain Neoplasms; Cell Line, Tumor; Combined Modality Therapy; Dacarbazine; Disease Progression; Female; Glioblastoma; Humans; Mice; Mice, Nude; Oxidative Stress; Physical Conditioning, Animal; Reactive Oxygen Species; Temozolomide | 2016 |